IS THE TIME TO PREVENT INTRAOPERATIVE MIOSIS
AND REDUCE POSTOPERATIVE OCULAR PAIN
FDA APPROVED
OMIDRIA
™
(phenylephrine and ketorolac injection) 1% / 0.3%
is the first and only FDA-approved treatment that both
1
:
Preemptively inhibits intraoperative miosis
Decreases postoperative ocular pain for 10 to 12 hours
OMIDRIA is preservative- and bisulfite-free
Easy to integrate into routine operating procedures
Add preoperatively to irrigation solution
1
One 4-mL single-patient-use vial to 500 mL
Can be added to irrigation solution in the surgical suite
No other preparation required
INDICATIONS AND USAGE
OMIDRIA is added to ophthalmic irrigation solution used during
cataract surgery or intraocular lens replacement and is indicated
for maintaining pupil size by preventing intraoperative miosis and
reducing postoperative ocular pain.
